The Role of Gut Microbiota and Their Derived Metabolites in Chemotherapy‐Induced Nausea and Vomiting in Ovarian Cancer [PDF]
Cancer MedicineObjective This study aimed to investigate the relationship between gut microbiota and chemotherapy‐induced nausea and vomiting (CINV) in patients with ovarian cancer undergoing platinum‐based chemotherapy (carboplatin or cisplatin combined with ...
Shuiling Zu +5 more
doaj +2 more sources
Effect of a nurse-led multidisciplinary team model on chemotherapy-induced nausea and vomiting in lung cancer patients [PDF]
Frontiers in OncologyObjectiveTo explore the effect of a nurse-led multidisciplinary team (MDT) model on chemotherapy-induced nausea and vomiting (CINV) in lung cancer patients.MethodsA total of 126 non-small cell lung cancer patients undergoing platinum-based chemotherapy ...
Wei Liu, Qian Peng, Xiuni Gan
doaj +2 more sources
Evaluating the potential to predict chemotherapy-induced nausea and vomiting in carboplatin-containing treatment based on symptoms induced by prior cisplatin-containing treatment [PDF]
Scientific ReportsChemotherapy-induced nausea and vomiting (CINV) is a serious adverse effect of cisplatin (CDDP)- and carboplatin (CBDCA)-containing treatments. In this study, we aimed to assess the potential to predict CINV in subsequent CBDCA-containing chemotherapy ...
Yoshitaka Saito +6 more
doaj +2 more sources
Guidelines versus individualized care for the management of CINV [PDF]
Supportive Care in Cancer, 2018 Numerous groups have published guidelines for the prevention and management of chemotherapy-induced nausea and vomiting (CINV). The current management of CINV, however, remains suboptimal, due in part to poor adherence to existing antiemetic guidelines.
Mark Clemons +2 more
exaly +3 more sources
Incidence and clinical characteristics of zolbetuximab-induced nausea and vomiting in CLDN18.2-positive unresectable advanced or recurrent gastric cancer: a retrospective study [PDF]
Journal of Pharmaceutical Health Care and SciencesBackground Zolbetuximab for CLDN18.2-positive advanced gastric cancer frequently causes chemotherapy-induced nausea and vomiting (CINV), particularly during the first infusion.
Yosuke Ando +16 more
doaj +2 more sources
Prevalence and risk factors for nausea and vomiting in breast cancer patients undergoing chemotherapy [PDF]
Acta OncologicaBackground and purpose: Chemotherapy-induced nausea and vomiting (CINV) is a common and severe adverse effect of breast cancer (BC) treatment that compromises treatment adherence and quality of life.
Yuhui Feng +4 more
doaj +2 more sources
Journal of Ayurveda and Integrative MedicineChemotherapy-induced nausea and vomiting (CINV) affects over 50% of pediatric patients undergoing chemotherapy, a higher proportion than in adults. CINV often occurs despite adequate antiemetic prophylaxis, hampering patients' willingness to continue the
Harri Hardi, Melva Louisa
exaly +3 more sources
Chemotherapy-induced nausea and vomiting among cancer patients in Shanghai: a cross-sectional study [PDF]
Zhongguo aizheng zazhi, 2023 Background and purpose: Chemotherapy-induced nausea and vomiting (CINV) can cause severe damage to body functions and even lead to death. The prevention of CINV is critically important in patients receiving emetogenic chemotherapy regimen.
Cheng ZENG +23 more
doaj +2 more sources
Asia-Pacific Journal of Oncology Nursing, 2021 Objective: This study aimed to assess the occurrence of chemotherapy-induced nausea and vomiting (CINV) in acute phase (24 h after chemotherapy) and delayed phase (2–5 days after chemotherapy) after standard antiemetic therapy and to explore the risk ...
Xinjuan Huang +9 more
doaj +1 more source
Nurse Media: Journal of Nursing, 2023 Background: Studies related to blood type in cancer patients have been conducted extensively, but they are inclined to cancer incidence or survival rate.
Dwi Kartika Rukmi, Muhamat Nofiyanto
doaj +1 more source